A strong MD Pathology thesis turns the material that already passes through the department, such as biopsies, cytology smears, blood samples and autopsy tissue, into a focused diagnostic or prognostic question. In Indian teaching hospitals the most feasible work correlates a histological, cytological or haematological finding with grade, stage or outcome, compares two diagnostic methods, or audits laboratory performance. Archived blocks and records allow larger series, while prospective work suits common lesions.

The catalogue covers Immunohistochemistry & Molecular Pathology, Cytopathology, Haematology, Surgical Pathology & Histopathology, Clinical Pathology, Laboratory Quality Management, Transfusion Medicine & Blood Bank and Autopsy Pathology. Typical titles study marker expression in common carcinomas, Helicobacter detection in gastric biopsies, prostate and liver biopsy panels, and tumour-associated macrophages. Objectives or a full synopsis can be bought for any title.

1What the MD Pathology catalogue covers

Our thesis-title catalogue, shared with our sister site medicalthesistopic.in, currently lists 419 MD Pathology titles. The newest ones are based on PubMed literature published in 2024–2026. Titles by subject area (top 8):

Subject areaTitles
Immunohistochemistry & Molecular Pathology80
Cytopathology78
Haematology62
Surgical Pathology & Histopathology58
Clinical Pathology42
Laboratory Quality Management40
Transfusion Medicine & Blood Bank32
Autopsy Pathology27

Most common study designs: retrospective record-based study (155), prospective analytical study (101), prospective observational study (70), hospital-based cross-sectional study (48), analytical cross-sectional study (40), community-based cross-sectional study (4). Each title already names its study design, so you can see at a glance whether it suits your department's patient load and your timeline.

Browse by subject area: Clinical Pathology Β· Cytopathology Β· Haematology Β· Immunohistochemistry & Molecular Pathology Β· Laboratory Quality Management Β· Surgical Pathology & Histopathology

250 recent MD Pathology thesis titles

These 50 titles are free to read. Discuss any of them with your guide before you commit; check that it has not already been taken up in your department.

  1. 001

    Computer-assisted semen analysis versus manual microscopy for sperm concentration and motility in men of infertile couples

    Clinical PathologyProspective analytical studyComparative Study
  2. 002

    Somatostatin receptor 2A immunohistochemistry in gastroenteropancreatic neuroendocrine tumours and its association with WHO grade

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  3. 003

    CK5/6 and EGFR immunohistochemistry for identifying the basal-like phenotype in triple-negative breast carcinoma and its association with grade

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  4. 004

    Concordance of ER, PR and HER2 status between core needle biopsy and subsequent excision specimens in invasive breast carcinoma

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  5. 005

    Residual cancer burden after neoadjuvant chemotherapy in breast carcinoma and its association with pre-treatment Ki-67 and molecular subtype

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  6. 006

    COX-2 immunohistochemical expression along the colorectal adenoma-carcinoma sequence and its association with dysplasia grade

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  7. 007

    HBME-1, galectin-3 and CK19 immunohistochemistry in differentiating benign from malignant follicular-patterned thyroid lesions

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyDiagnostic Accuracy
  8. 008

    Nuclear beta-catenin immunohistochemistry in distinguishing desmoid fibromatosis from other fibroblastic and spindle cell lesions

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyDiagnostic Accuracy
  9. 009

    PD-L1 (22C3) combined positive score in triple-negative breast carcinoma and its association with tumour-infiltrating lymphocytes

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  10. 010

    Mismatch repair deficiency by immunohistochemistry in gastric adenocarcinoma and its association with Lauren histological type and stage

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  11. 011

    KRAS mutation analysis by real-time PCR in colorectal carcinoma and its association with clinicopathological features and MMR status

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  12. 012

    Immunohistochemical subtyping of ampullary carcinoma into intestinal and pancreatobiliary types using CK7, CK20, CDX2 and MUC1

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyClinical Spectrum / Profile
  13. 013

    Inhibin and calretinin immunohistochemistry in the diagnosis of ovarian sex cord-stromal tumours and their distinction from mimics

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyDiagnostic Accuracy
  14. 014

    Glypican-3, HepPar-1 and arginase-1 immunohistochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma in liver biopsies

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyDiagnostic Accuracy
  15. 015

    AMACR (racemase) and p63 immunohistochemistry in the diagnosis of small foci of adenocarcinoma in prostatic needle biopsies

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyDiagnostic Accuracy
  16. 016

    Loss of PTEN expression in endometrial hyperplasia and endometrioid carcinoma and its diagnostic role in atypical hyperplasia

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  17. 017

    CD68 and CD163 tumour-associated macrophages in oral squamous cell carcinoma and their association with nodal metastasis and grade

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  18. 018

    Immunohistochemistry versus Giemsa staining for detection of Helicobacter pylori in gastric biopsies with chronic gastritis

    Immunohistochemistry & Molecular PathologyProspective analytical studyComparative Study
  19. 019

    Microvessel density by CD34 immunohistochemistry in colorectal carcinoma and its association with tumour stage and nodal metastasis

    Immunohistochemistry & Molecular PathologyAnalytical cross-sectional studyAssociation / Correlation
  20. 020

    HER2 overexpression in colorectal adenocarcinoma and its association with tumour location, grade and stage

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  21. 021

    Claudin 18.2 expression by immunohistochemistry in gastric adenocarcinoma and its association with HER2 status and tumour stage

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  22. 022

    p53 and Ki-67 expression across grades of oral epithelial dysplasia and oral squamous cell carcinoma

    Immunohistochemistry & Molecular PathologyAnalytical cross-sectional studyAssociation / Correlation
  23. 023

    p16 immunohistochemistry as a surrogate marker of HPV in oropharyngeal squamous cell carcinoma and its clinicopathological correlates

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  24. 024

    E-cadherin immunohistochemistry in distinguishing invasive lobular from invasive ductal breast carcinoma

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyDiagnostic Accuracy
  25. 025

    HER2 FISH amplification in breast carcinomas with equivocal (2+) immunohistochemistry according to ASCO/CAP guidelines and associated clinicopathological features

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyDiagnostic Accuracy
  26. 026

    Hot-spot versus global scoring of Ki-67 index in invasive breast carcinoma according to International Ki67 in Breast Cancer Working Group recommendations

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyComparative Study
  27. 027

    Immunohistochemical profile of classical Hodgkin lymphoma with CD15, CD30, PAX5 and EBV-LMP1 and its association with histological subtype

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyClinical Spectrum / Profile
  28. 028

    Cyclin D1 and SOX11 immunohistochemistry in the diagnosis of mantle cell lymphoma and its distinction from other small B-cell lymphomas

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyDiagnostic Accuracy
  29. 029

    TTF-1 and Napsin A immunohistochemistry in distinguishing primary lung adenocarcinoma from metastatic adenocarcinoma in lung biopsies

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyDiagnostic Accuracy
  30. 030

    p40 versus p63 immunohistochemistry in distinguishing squamous cell carcinoma from adenocarcinoma in small lung biopsies

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyComparative Study
  31. 031

    SATB2 versus CDX2 immunohistochemistry in identifying colorectal origin of metastatic adenocarcinoma

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyDiagnostic Accuracy
  32. 032

    NKX3.1 versus PSA immunohistochemistry in establishing prostatic origin of metastatic carcinoma in biopsy specimens

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyDiagnostic Accuracy
  33. 033

    BRAF V600E (VE1) immunohistochemistry in papillary thyroid carcinoma and its association with histological variant and extrathyroidal extension

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  34. 034

    PD-L1 (22C3) tumour proportion score in non-small cell lung carcinoma biopsies and its association with histological subtype and EGFR mutation status

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  35. 035

    Mismatch repair protein immunohistochemistry in endometrial carcinoma and its association with histological type, grade and myometrial invasion

    Immunohistochemistry & Molecular PathologyRetrospective record-based studyAssociation / Correlation
  36. 036

    Rate of unsatisfactory cervical Pap smears and the effect of collection device and smear technique on specimen adequacy

    CytopathologyProspective observational studyAssociation / Correlation
  37. 037

    Cervicovaginal cytological changes and infections on Pap smear in women using copper intrauterine contraceptive devices

    CytopathologyHospital-based cross-sectional studyClinical Spectrum / Profile
  38. 038

    Nuclear and cytoplasmic morphometry of exfoliated buccal mucosal cells in patients with type 2 diabetes mellitus compared with healthy controls

    CytopathologyAnalytical cross-sectional studyAssociation / Correlation
  39. 039

    Ultrasound-guided FNAC of hepatic masses: cytomorphological distinction of hepatocellular carcinoma from metastatic adenocarcinoma with cell block correlation

    CytopathologyProspective analytical studyDiagnostic Accuracy
  40. 040

    Flow cytometric immunophenotyping on lymph node aspirates in suspected non-Hodgkin lymphoma and its concordance with histopathology and IHC

    CytopathologyProspective analytical studyDiagnostic Accuracy
  41. 041

    Biliary brush cytology during ERCP in patients with biliary strictures and its diagnostic accuracy against histopathology and clinical follow-up

    CytopathologyRetrospective record-based studyDiagnostic Accuracy
  42. 042

    Papanicolaou, May-Grunwald-Giemsa and rapid haematoxylin-eosin stains on FNAC smears: comparison of cytomorphological detail and diagnostic accuracy

    CytopathologyProspective analytical studyComparative Study
  43. 043

    Cytomorphological spectrum of scrotal and testicular swellings on FNAC with histopathological correlation

    CytopathologyRetrospective record-based studyClinical Spectrum / Profile
  44. 044

    Koilocytic changes on Pap smear and their correlation with high-risk HPV DNA positivity in women with cervical squamous intraepithelial lesions

    CytopathologyHospital-based cross-sectional studyAssociation / Correlation
  45. 045

    Added diagnostic value of cell blocks prepared from residual needle-rinse material over conventional FNAC smears in palpable and deep-seated lesions

    CytopathologyProspective analytical studyComparative Study
  46. 046

    Spectrum of epithelial cell abnormalities and atrophic changes on Pap smears of postmenopausal women

    CytopathologyHospital-based cross-sectional studyClinical Spectrum / Profile
  47. 047

    Cytomorphological features distinguishing fibroadenoma from phyllodes tumour on breast FNAC with histopathological correlation

    CytopathologyRetrospective record-based studyDiagnostic Accuracy
  48. 048

    Cytomorphological spectrum of male breast lesions on FNAC with emphasis on gynaecomastia and carcinoma

    CytopathologyRetrospective record-based studyClinical Spectrum / Profile
  49. 049

    Urine cytology for decoy cells in renal transplant recipients and its association with BK polyomavirus viruria and graft dysfunction

    CytopathologyProspective observational studyAssociation / Correlation
  50. 050

    Auramine-rhodamine fluorescent staining versus Ziehl-Neelsen staining for acid-fast bacilli on FNAC smears of suspected tuberculous lymphadenitis

    CytopathologyProspective analytical studyComparative Study

3Download MD Pathology titles in Excel (β‚Ή1 per title)

Want more than these 50? Download an Excel of the newest titles: latest 100 for β‚Ή100, latest 500 for β‚Ή500, or all 419 titles at β‚Ή1 each. Or search a keyword (for example a disease or test) and pay only for the titles found. Pay by UPI, QR or card; the Excel downloads instantly.

πŸ“₯ MD Pathology Titles in Excel Β· β‚Ή1 per title

100 titles = β‚Ή100. Secure checkout (UPI / QR / card) on our sister site medicalthesistopic.in; the Excel downloads instantly.

1 Β· Speciality package (newest first)

2 Β· Or search a keyword

Or browse free titles by speciality β†’

4Objectives and synopsis for any title

Liked a title? Each one has two optional paid add-ons on medicalthesistopic.in, paid separately there:

  • Objectives (β‚Ή50): research question, aim, primary and secondary objectives, hypothesis and outcome measures for that exact title.
  • Full Plan / Synopsis (β‚Ή500): a complete synopsis draft for that title, from introduction and review-of-literature search plan to sample size working, methodology and statistical plan.

Use the buttons under each title above; they open that title on medicalthesistopic.in. Treat the output as a first draft to edit with your guide, and read how to write aims and objectives before you finalise yours.

5Tips for choosing a MD Pathology topic

  • Price every immunohistochemistry marker before finalising the title; antibodies and detection kits are costly, so limit the panel to markers that answer the question and check whether the department or a grant will fund them.
  • For cytopathology theses, use a standard reporting system such as Bethesda for thyroid or the Milan system for salivary gland, and plan histopathological follow-up so you can calculate diagnostic accuracy.
  • Retrospective block-based studies are quick, but confirm that archived blocks and slides are retrievable and well preserved, and that stage and outcome are recorded well enough to support the planned correlations.
  • Laboratory quality and blood bank studies need little extra cost; use recognised indicators such as turnaround time, error rates and sample rejection, and align them with NABL requirements or the existing quality programme.

For the general checklist (patient load, timeline, cost, ethics), see how to choose an MD/MS thesis topic. Every titles page for other specialities is listed on thesis topics by speciality.

6Need help with your thesis?

PubMedico's team helps MD Pathology residents with synopsis writing, sample size, statistics and the final thesis draft. WhatsApp +91 78787 33004 for a free thesis guidance.

❓ Frequently Asked Questions

Quick answers to common questions on this topic

Which pathology thesis topics finish fastest?+

Retrospective histopathology or cytology series, laboratory quality audits and blood bank studies usually finish fastest because the material or data already exist. Prospective studies that need histopathological follow-up of cytology, or immunohistochemistry on fresh cases, take longer and depend on case flow. Check how often the lesion reaches your department before choosing.

Is immunohistochemistry essential for a good MD Pathology thesis?+

No. IHC adds value when a marker has a clear diagnostic or prognostic role, but many strong theses rely on morphology, special stains, cytology reporting systems or haematology analysers. A well-designed correlation of routine morphology with grade, stage or outcome is often more feasible and equally acceptable to examiners and universities.

Do autopsy pathology theses need separate permission?+

Yes. Beyond institutional ethics committee approval, you need agreement from the forensic medicine department to access medico-legal autopsy tissue, and clear consent rules for clinical autopsies. Plan sampling, fixation and staining protocols in advance, because autopsy material may show autolysis that affects interpretation and weakens your conclusions.

Can I use these MD Pathology titles directly as my thesis title?+

Use them as starting points. Discuss the title with your guide, check that it fits your department's patients and facilities, check it has not already been done at your institution, and adjust the wording before you submit it to your ethics committee.